These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1632587)

  • 1. High potency cocaine analogs: neurochemical, imaging, and behavioral studies.
    Boja JW; Cline EJ; Carroll FI; Lewin AH; Philip A; Dannals R; Wong D; Scheffel U; Kuhar MJ
    Ann N Y Acad Sci; 1992 Jun; 654():282-91. PubMed ID: 1632587
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis, dopamine transporter affinity, dopamine uptake inhibition, and locomotor stimulant activity of 2-substituted 3 beta-phenyltropane derivatives.
    Xu L; Kelkar SV; Lomenzo SA; Izenwasser S; Katz JL; Kline RH; Trudell ML
    J Med Chem; 1997 Mar; 40(6):858-63. PubMed ID: 9083474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in binding site density of dopamine transporter in the striatum, orbitofrontal cortex, and amygdala in early Parkinson's disease: compartment analysis for beta-CFT binding with positron emission tomography.
    Ouchi Y; Yoshikawa E; Okada H; Futatsubashi M; Sekine Y; Iyo M; Sakamoto M
    Ann Neurol; 1999 May; 45(5):601-10. PubMed ID: 10319882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3'-Chloro-3 alpha-(diphenylmethoxy)tropane but not 4'-chloro-3 alpha-(diphenylmethoxy)tropane produces a cocaine-like behavioral profile.
    Kline RH; Izenwasser S; Katz JL; Joseph DB; Bowen WD; Newman AH
    J Med Chem; 1997 Mar; 40(6):851-7. PubMed ID: 9083473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral effects of novel cocaine analogs: a comparison with in vivo receptor binding potency.
    Cline EJ; Scheffel U; Boja JW; Carroll FI; Katz JL; Kuhar MJ
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1174-9. PubMed ID: 1545384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positron emission tomography of cocaine binding sites on the dopamine transporter.
    Madras BK; Elmaleh DR; Meltzer PC; Liang AY; Brownell GL; Brownell AL
    NIDA Res Monogr; 1994; 138():57-69. PubMed ID: 7603545
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-lasting inhibition of in vivo cocaine binding to dopamine transporters by 3 beta-(4-iodophenyl)tropane-2-carboxylic acid methyl ester: RTI-55 or beta CIT.
    Volkow ND; Gatley SJ; Fowler JS; Chen R; Logan J; Dewey SL; Ding YS; Pappas N; King P; MacGregor RR
    Synapse; 1995 Mar; 19(3):206-11. PubMed ID: 7784960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positron emission tomographic imaging of the dopamine transporter with 11C-WIN 35,428 reveals marked declines in mild Parkinson's disease.
    Frost JJ; Rosier AJ; Reich SG; Smith JS; Ehlers MD; Snyder SH; Ravert HT; Dannals RF
    Ann Neurol; 1993 Sep; 34(3):423-31. PubMed ID: 8363363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altropane, a SPECT or PET imaging probe for dopamine neurons: III. Human dopamine transporter in postmortem normal and Parkinson's diseased brain.
    Madras BK; Gracz LM; Fahey MA; Elmaleh D; Meltzer PC; Liang AY; Stopa EG; Babich J; Fischman AJ
    Synapse; 1998 Jun; 29(2):116-27. PubMed ID: 9593102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PET.
    Tissingh G; Bergmans P; Winogrodzka A; Stoof JC; Wolters EC; Booij J; Van Royen EA
    J Nucl Med; 1997 Aug; 38(8):1271-2. PubMed ID: 9255164
    [No Abstract]   [Full Text] [Related]  

  • 11. 11C-WIN 35,428 for detecting dopamine depletion in mild Parkinson's disease.
    Madras BK
    Ann Neurol; 1994 Mar; 35(3):376-7. PubMed ID: 8122895
    [No Abstract]   [Full Text] [Related]  

  • 12. Anhydroecgonine methyl ester, a cocaine pyrolysis product, may contribute to cocaine behavioral sensitization.
    Garcia RC; Torres LH; Balestrin NT; Andrioli TC; Flório JC; de Oliveira CD; da Costa JL; Yonamine M; Sandoval MR; Camarini R; Marcourakis T
    Toxicology; 2017 Feb; 376():44-50. PubMed ID: 27129946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid detection of Parkinson's disease by SPECT with altropane: a selective ligand for dopamine transporters.
    Fischman AJ; Bonab AA; Babich JW; Palmer EP; Alpert NM; Elmaleh DR; Callahan RJ; Barrow SA; Graham W; Meltzer PC; Hanson RN; Madras BK
    Synapse; 1998 Jun; 29(2):128-41. PubMed ID: 9593103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson disease.
    Innis RB; Seibyl JP; Scanley BE; Laruelle M; Abi-Dargham A; Wallace E; Baldwin RM; Zea-Ponce Y; Zoghbi S; Wang S
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11965-9. PubMed ID: 8265656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rotational behavior induced by cocaine analogs in rats with unilateral 6-hydroxydopamine lesions of the substantia nigra: dependence upon dopamine uptake inhibition.
    Heikkila RE; Cabbat FS; Manzino L; Duvoisin RC
    J Pharmacol Exp Ther; 1979 Oct; 211(1):189-94. PubMed ID: 573788
    [No Abstract]   [Full Text] [Related]  

  • 16. Displacement of RTI-55 from the dopamine transporter by cocaine.
    Gatley SJ; Volkow ND; Chen R; Fowler JS; Carroll FI; Kuhar MJ
    Eur J Pharmacol; 1996 Jan; 296(2):145-51. PubMed ID: 8838450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel 3alpha-diphenylmethoxytropane analogs: selective dopamine uptake inhibitors with behavioral effects distinct from those of cocaine.
    Katz JL; Izenwasser S; Kline RH; Allen AC; Newman AH
    J Pharmacol Exp Ther; 1999 Jan; 288(1):302-15. PubMed ID: 9862785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacological relevance of the cocaine binding site in mouse brain.
    Sershen H; Reith ME; Lajtha A
    Neuropharmacology; 1980 Nov; 19(11):1145-8. PubMed ID: 7442945
    [No Abstract]   [Full Text] [Related]  

  • 19. Novel N-substituted 3 alpha-[bis(4'-fluorophenyl)methoxy]tropane analogues: selective ligands for the dopamine transporter.
    Agoston GE; Wu JH; Izenwasser S; George C; Katz J; Kline RH; Newman AH
    J Med Chem; 1997 Dec; 40(26):4329-39. PubMed ID: 9435902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging studies in movement disorders.
    Seibyl JP
    Semin Nucl Med; 2003 Apr; 33(2):105-13. PubMed ID: 12756643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.